Did you know that the “four-hit” hypothesis for IgA nephropathy #IgAN was first clearly articulated by Hitoshi Suzuki et al. in their 2011 J. Am. Soc. Nephrol. paper, “The pathophysiology of IgA nephropathy.”
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/21949093/

Therapeutic targets 🎯and positioning of treatments in IgA nephropathy 🔬 #IgAN ca. 2026 from @kidneyint.bsky.social
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/41895685/

PISCES: Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis ca. 2026 from @nejm.org
@asnkidney.bsky.social
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/41201837/
👉 www.kidneynews.org/view/journal...

Efficacy and Safety of Atrasentan in Patients with #IgAN Receiving Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) ca. 2026 from @asnpublications.bsky.social
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky

Photo Credit: @nephroseeker.medsky.social

👉 journals.lww.com/jasn/fulltex...

Trying to catch up with #IgAN trials⁉️

Check out 👉 “IgAN: An Overview of the Clinical Trials” ca. 2025 from @kidneymed.bsky.social @haresh11.bsky.social @alexgr23.bsky.social @saynanorouzi.bsky.social
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/41050133/

SGLT2 inhibition: Pleiotropic direct cardiac and kidney effects ⁉️
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/35589167/

The draft of the @kdigo.org 2026 Clinical Practice Guideline for Acute Kidney Injury and Acute Kidney Disease is now available for public review through 🗓️ April 27, 2026
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky

👉 kdigo.org/guidelines/a...
👉 FEEDBACK Form www.surveymonkey.com/r/GTGNFHG

Approach to immune checkpoint inhibitor (ICI) nephrotoxicity and rechallenge
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Onconephrology 🦀 #Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/32775813/

Diagnostic approach to hypophosphatemia
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/34754427/

Practical suggestions for the diagnosis and management of hypertension before, during, and after the start of anticancer therapy
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Onconephrology 🦀 #Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/36621810/

Cancer Therapy Related Hypertension
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Onconephrology 🦀 #Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/36621810/

Pathogenesis of IgA Nephropathy #IgAN
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/37742867/

Hypomagnesemia
📌 Manifestations and its association with cancer
📌 Causes in patients with cancer
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Onconephrology 🦀 #Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/37086496/

Individualized management of malignancy-associated hypercalcemia
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Onconephrology 🦀 #Nephpearls #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/41623290/

Pillars of IgA Nephropathy #IgAN Treatment
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/38398259/

Pillars of Treatment for Diabetic Kidney Disease secondary to Type 2 Diabetes (T2D)
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky

👉🏼 medicinetoday.com.au/mt/2024/dece...

Timely publication on "@asnkidney.bsky.social Kidney Health Guidance on Conservative Management in People with Kidney Failure" ca. 2026 from @asnpublications.bsky.social
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵 #Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/41848800/

Cardiovascular-Kidney-Metabolic (CKM) Syndrome Stages: Identify Chronic Kidney Disease (CKD) as an important risk ⚠️ for adverse outcomes
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵 #Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/37807924/

If you're attending #WCN26 🇯🇵 #WCN2026 🇯🇵 do not miss @kdigo.org Guideline Education Meeting (GEM) #KDIGOGEMS 💎
#Nephpearls #NephSky

🗓️ Friday, March 27, 2026
⏰ 09:00 – 16:00 JST
📍 Room 303, Pacifico Yokohama Conference Center

Learn more: kdigo.co/WCN26-KDIGO-...

A focused update to @kdigo.org 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) has been initiated
#Nephpearls #NephSky

📌 The update will focus on "Delaying CKD progression and managing its complications”

👉 www.surveymonkey.com/r/P9GHNBY

The draft of @kdigo.org 2026 Clinical Practice for Diabetes and Chronic Kidney Disease (CKD) is available for public review through 🗓️ April 13, 2026
#Nephpearls #NephSky

We invite you to review the draft and share comments to help inform the final guideline

👉 kdigo.org/guidelines/d...

UACR (urinary albumin-to-creatinine ratio) can direct personalized prevention and treatment for cardiovascular (CVD) and chronic kidney disease (CKD) ca. 2026
#Nephpearls #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/41633942/

In conjunction w/ @theisn.org
World Congress of Nephrology & Tokushukai Medical Group, @kdigo.org will host a full-day Guideline Education Meeting (GEM)
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵 #Nephpearls #KDIGOGEMS 💎 #NephSky

👉🏼 kdigo.org/events/kdigo...

Hypomagnesemia (Outpatient): Diagnostic algorithm from @kidneyboy.bsky.social
#Nephpearls #NephSky

👉 shop.lww.com/Manual-of-Ne...

Diuretic management in patients w/ kidney AKI & acute heart failure ca. 2026 from @kdigo.org @kidneyint.bsky.social
#Nephpearls #Cardiorenal #NephSky

📌 This algorithm provides a list of what to look for when assessing optimal response to a diuretic regimen

👉 pubmed.ncbi.nlm.nih.gov/41791738/

Conceptual framework for the medical management of heart failure (HF) with reduced or preserved ejection fraction (HFrEF or HFpEF) and chronic kidney disease (CKD) ca. 2026 from @kdigo.org @kidneyint.bsky.social
#Nephpearls #Cardiorenal #NephSky

👉 pubmed.ncbi.nlm.nih.gov/41793402/

GDMT for HFpEF and HFrEF
#Nephpearls #Cardiorenal #NephSky

👉🏼 www.acc.org/Education-an...

Check out our review "IgA Nephropathy #IgAN: An Overview of the Clinical Trials" #Nephmadness write up
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/41050133/

👉 NephMadness ajkdblog.org/2026/03/01/n...

C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies ca. 2026 from @kidneymed.bsky.social @saynanorouzi.bsky.social

📢 This paper is a very timely read for #NephMadness
#Nephpearls #NephSky

👉🆓 www.sciencedirect.com/science/arti...

👉 ajkdblog.org/2026/03/01/n...

It’s March once again … #Nephmadness has begun #Nephpearls #NephSky

👉🏼 ajkdblog.org
👉🏼 If you don’t know what it’s about, then it’s time to checkout this 📺 m.youtube.com/watch?v=tZUR...